Tuesday 23rd April 2024
RAIRDA Survey
Have your say on the way your services are working for your Rare Autoimmune Rheumatic Disease (RAIRD)
Calcium channel blockers can be used to treat the symptoms of Raynaud’s. A new drug, Nisoldipine, a calcium channel blocker, was tested for the treatment in Raynaud’s in a trial.
Calcium channel blockers can be used to treat the symptoms of Raynaud's. A new drug, Nisoldipine, a calcium channel blocker, was tested for the treatment in Raynaud's in a trial.
The trial of 19 patients showed that Nisoldipine significantly reduced the frequency of Raynaud's attacks.
But didn't show to reduce the severity of attacks.
Side-effects were uncommon.
The scientific research and references.
Nisoldipine is normally used alone or together with other medicines to treat high blood pressure, and could possibly be used to treat Raynaud's in the future.
Nisoldipine is a calcium channel blocker. It works by affecting the movement of calcium into the cells of the heart and blood vessels. As a result, it relaxes blood vessels and increases the supply of blood and oxygen. In Raynaud's the blood vessels otherwise constrict to prevent blood flow.
If this drug were to be used for Raynaud's it could only be done so with a doctor's prescription to weigh up the risks, and any possible side effects of taking the medicine against the good it will do. This is a decision you and your doctor will make and the dose of this medicine will be different for different patients. It is important that your doctor checks your progress with regular visits to make sure this medicine is working properly and to check for unwanted effects.
Tuesday 23rd April 2024
Have your say on the way your services are working for your Rare Autoimmune Rheumatic Disease (RAIRD)
Tuesday 19th March 2024
The Scleroderma and Raynaud’s UK sponsored 'Science in Medicine School Teams Prize 2024' contest is now open for entries. The contest aims to engage sixth form school students with science in medicine, and challenges students to prepare an ePoster with a novel vision on how to promote the health and well-being of individuals with Scleroderma and/or Raynaud’s. If you're interested in entering, or know someone in sixth form who might be, read on to find out more!
Wednesday 28th February 2024
As high bills continue to threaten the health of those living with the debilitating condition; SRUK is appealing to energy companies to provide financial assistance to them.